Trial intelligence / Profile preview

Cariprazine in Bipolar Depression

NCT00852202Phase 2Completed

Sponsor
Forest Laboratories
Start
Jun 2009
Primary completion
Jun 2010
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 2 trial of cariprazine in bipolar disorder (BD), sponsored by Forest Laboratories. Started Jun 2009; status: completed.

02

Drugs

cariprazine
03

Conditions

bipolar disorder (BD)

Beyond the preview

Go deeper on NCT00852202.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00852202.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call